Post-market SUrveiLlance RegiStry for the Endogenex System (Endogenex PULSE Registry)

Endogenex PULSE Registry

Status

Enrolling by invitation

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT07197775

Enrollment

500

Registered

2025-09-29

Start date

2026-03-11

Completion date

2032-05-01

Last updated

2026-07-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes, Diabetes Mellitus, Type 2, Type2Diabetes, Type 2 Diabetes, Type 2 Diabetes Mellitus (T2DM)

Brief summary

This registry is designed to collect long-term data and support ongoing post-market surveillance of real-world data for the Endogenex System.

Detailed description

This is an observational registry that is designed to facilitate long-term patient follow-up for up to 5 years after an Endogenex procedure. It is structured to enable systematic longitudinal data collection on the safety and long-term clinical outcomes associated with the Endogenex System.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Type 2 diabetes * Have been treated with the Endogenex System * Consented to participate in the Endogenex PULSE Registry

Exclusion criteria

* Unwilling or unable to attend study visits * Unwilling or unable to provide medical records to study sites

Design outcomes

Primary

Measure	Time frame	Description
Incidence of adverse events	Through 5 years	Incidence of device-related and/or procedure-related adverse events

Countries

Australia, United States

Outcome results